Cancer Research UK logo.
SearchDonate
  • Search

A trial of a vaccine for nasopharyngeal cancer that contains the Epstein Barr virus

Overview

Cancer types:

Head and neck cancers, Nasopharyngeal cancer, Pharyngeal cancer

Status:

Results

Phase:

Phase 1

Details

This trial looked at a vaccine that might help the immune system to recognise and kill nasopharyngeal cancer cells that contained a virus called Epstein Barr.

Nasopharyngeal cancer is a cancer that begins in the part of your throat called the nasopharynx.

Cancer Research UK supported this trial.

Recruitment start: 1 June 2013

Recruitment end: 10 March 2015

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Neil Steven

Supported by

Cancer Research UK (Centre for Drug Development)

NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUKD/13/001.

Last reviewed: 17 May 2018

CRUK internal database number: 2563

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.